Table 1.

Bacterial strains used in the study.

Isolates	Source	Antibiotic Resistance *	Reference
P. aeruginosa_Mi_1 †	Blood	S	[25]
P. aeruginosa_Mi_2 †	Sputum	S	[25]
P. aeruginosa_Mi_6 †	Urine	S	[25]
P. aeruginosa_Mi_7 †	Sputum	S	[25]
P. aeruginosa_Ba_164 †	Prosthetic biofilm	S	[25]
P. aeruginosa_Ba_168 †	Prosthetic biofilm	S	[25]
P. aeruginosa_Ba_169 †	Prosthetic biofilm	S	[25]
P. aeruginosa_Trac_20 †	Tracheal secretion	S	[25]
P. aeruginosa_Trac_23 †	Tracheal secretion	S	[25]
P. aeruginosa_Ren_1 †	Saliva	S	[25]
P. aeruginosa_ATCC 27853 ‡	Blood	S	[25]
P. aeruginosa_ATCC 2108 ‡	Sputum	AMK, CFZ, CTX, GEN, IMP, TGC	[25]
P. aeruginosa_ATCC 2110 ‡	Sputum	AMP, CFZ, CTX, FOX, NIT, TGC, SXT	[25]
P. aeruginosa_ATCC 2112 ‡	Sputum	AMC, AMP, CFZ, CPD, CRO, CTX, CXM, FOX, NIT, SXT, TET, TGC,	[25]
P. aeruginosa_ATCC 2113 ‡	Sputum	AMP, AMC, CFZ, CTX, NIT, SAM, SXT	[25]

^† Human Exposome and Infectious Diseases Network collection. ^‡ American Type Culture Collection. * S: Susceptible to all antimicrobial agents tested; AMC: amoxicillin-clavulanic acid; AMK: amikacin; AMP: ampicillin; CFZ: cefazolin; CPD: cefpodoxime; CRO: ceftriaxone; CTX: cefotaxime; CXM: cefuroxime; FOX: cefoxitin; GEN: gentamicin; IMP: imipenem; NIT: nitrofurantoin; SAM: ampicillin-sulbactam; SXT: trimethoprim-sulfamethoxazole; TET: tetracycline; TGC: tigecycline.